✦ LIBER ✦

A new extended-release niacin (niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients

✍ Scribed by John M Morgan; David M Capuzzi; John R Guyton

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of an extended-relea

✍ David M Capuzzi; John R Guyton; John M Morgan; Anne C Goldberg; Robert A Kreisbe 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Efficacy and tolerability of extended-re

✍ Harold E. Bays; Arvind Shah; Jianxin Lin; Christine McCrary Sisk; John F. Paolin 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 278 KB

Lipid-modifying efficacy and tolerabilit

✍ D. Maccubbin; H. E. Bays; A. G. Olsson; V. Elinoff; A. Elis; Y. Mitchel; W. Sira 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB

SAFETY PROFILE OF EXTENDED-RELEASE NIACI

✍ McKenney, J.; Bays, H.; Koren, M.; Ballantyne, C.; Maccubbin, D.; Mitchel, Y.; B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Long-term Safety and Efficacy of Triple

✍ John R. Guyton; Sergio Fazio; Adam Polis; Adeniyi Adewale; Joanne E. Tomassini; 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 57 KB

EFFICACY AND SAFETY OF EZETIMIBE/SIMVAST

✍ FAZIO, S; BROWN, B; GUYTON, J; POLIS, A; TOMASSINI, J; TERSHAKOVEC, A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 170 KB